Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Bos MEMM"'
Autor:
Malmberg R; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Medical Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., van Doorn L; Department of Medical Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Cox JM; Department of Clinical Pharmacy and Maasstad Lab, Maasstad Hospital, Rotterdam, the Netherlands., Daloul A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Ettafahi H; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Zietse M; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Koch BCP; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., van Leeuwen RWF; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Medical Oncology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Sep; Vol. 20 (9), pp. 1243-1251. Date of Electronic Publication: 2024 Jun 07.
Autor:
Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum AGJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoogstraat M; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bounova G; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Biometrics department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Data center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, the Netherlands., Canisius S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Biometrics department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, the Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bos MEMM; Department of Internal Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Bakker S; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kester L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rutgers EJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Menezes RX; Biostatistics Centre, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands., Kok M; Division of Tumor biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center, Utrecht, the Netherlands.
Publikováno v:
IScience [iScience] 2024 Jun 29; Vol. 27 (8), pp. 110425. Date of Electronic Publication: 2024 Jun 29 (Print Publication: 2024).
Autor:
Janssen SHM; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, the Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands., Vlooswijk C; Research and Development, Netherlands Comprehensive Cancer Organization, 3511 DT, Utrecht, The Netherlands., Bijlsma RM; Department of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Centers, 1105 AZ, Amsterdam, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands., Lalisang RI; Division of Medical Oncology, Department of Internal Medicine, Maastricht UMC+ Comprehensive Cancer Center, GROW-School of Oncology and Reproduction, Maastricht University Medical Center+, 6229 HX, Maastricht, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands., Kouwenhoven MCM; Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081 HV, Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands., Husson O; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, the Netherlands. o.husson@erasmusmc.nl.; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands. o.husson@erasmusmc.nl.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, the Netherlands. o.husson@erasmusmc.nl.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 May 13. Date of Electronic Publication: 2024 May 13.
Autor:
van der Meer DJ; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, North Holland, The Netherlands.; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Zevenbergen S; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, North Holland, The Netherlands.; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Vlooswijk C; Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, Utrecht, The Netherlands., Bijlsma RM; Department of Medical Oncology, University Medical Center, Utrecht, Utrecht, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, North Holland, The Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, North Holland, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, South Holland, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Lalisang RI; Department of Internal Medicine, Division of Medical Oncology, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, Maastricht, Limburg, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kouwenhoven MCM; Department of Neurology, Amsterdam University Medical Centers, Amsterdam, North Holland, The Netherlands.; Cancer Center Amsterdam, Cancer treatment and quality of life, Amsterdam, North Holland, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, North Holland, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, South Holland, The Netherlands., Husson O; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, North Holland, The Netherlands.; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, South Holland, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2024 Apr 04; Vol. 29 (4), pp. e526-e534.
Autor:
Lehmann V; Department of Medical Psychology, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. v.lehmann@amsterdamumc.nl.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands. v.lehmann@amsterdamumc.nl., Vlooswijk C; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Bijlsma R; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Center/University of Amsterdam, Amsterdam, The Netherlands., Bos MEMM; Department of Medical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Lalisang RI; Department of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC, Maastricht, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kouwenhoven MCM; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Department of Neurology, Amsterdam University Medical Centers/University of Amsterdam, Amsterdam, The Netherlands., Lok CAR; Department of Gynecologic Oncology, Center Gynaecologic Oncology Amsterdam, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Beerendonk CCM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Dinkelman-Smit M; Department of Urology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Husson O; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Feb 06. Date of Electronic Publication: 2024 Feb 06.
Autor:
Vrancken Peeters NJMC; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam; Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam., Vlooswijk C; Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht., Bijlsma RM; Department of Medical Oncology, University Medical Centre, Utrecht., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Centres, Amsterdam., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam., van der Hulle T; Department of Medical Oncology, Leiden University Medical Centre, Leiden., Lalisang RI; Department of Internal Medicine, Division of Medical Oncology, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Centre, Maastricht., Nuver J; Department of Medical Oncology, University Medical Centre Groningen, Groningen., Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Amsterdam University Medical Centres, Amsterdam., van der Ploeg IMC; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam., Husson O; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands. Electronic address: o.husson@nki.nl.
Publikováno v:
ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102234. Date of Electronic Publication: 2024 Jan 27.
Autor:
Gavioli C; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands., Vlooswijk C; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands., Janssen SHM; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Center, 1105 AZ, Amsterdam, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD, Rotterdam, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD, Rotterdam, The Netherlands., Lalisang RI; Department of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, 6229 HX, Maastricht, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands., Bijlsma RM; Department of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081 HV, Amsterdam, The Netherlands., Husson O; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. o.husson@erasmusmc.nl.; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands. o.husson@erasmusmc.nl.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands. o.husson@erasmusmc.nl., Beijer S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2024 Jan 15. Date of Electronic Publication: 2024 Jan 15.
Autor:
Bootsma TI; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands., van de Wal D; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands., Vlooswijk C; Research and Development, Netherlands Comprehensive Cancer Organization, 3511, DT, Utrecht, The Netherlands., Roos DC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015, GD, Rotterdam, The Netherlands., Drabbe C; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands., Tissier R; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066, CX, Amsterdam, The Netherlands., Bijlsma RM; Department of Medical Oncology, University Medical Center Utrecht, 3584, CX, Utrecht, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, 6525, GA, Nijmegen, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Centers, 1105, AZ, Amsterdam, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015, GD, Rotterdam, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, 2333, ZA, Leiden, The Netherlands., Lalisang RI; Department of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, 6229 HX, Maastricht, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, 9713, GZ, Groningen, The Netherlands., Kouwenhoven MCM; Department of Neurology, Cancer Center Amsterdam, Brain Tumor Center, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081, HV, Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015, GD, Rotterdam, The Netherlands., Janssen SHM; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands.; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066, CX, Amsterdam, The Netherlands., Husson O; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066, CX, Amsterdam, The Netherlands. o.husson@erasmusmc.nl.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015, GD, Rotterdam, The Netherlands. o.husson@erasmusmc.nl.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jan 13; Vol. 32 (2), pp. 104. Date of Electronic Publication: 2024 Jan 13.
Autor:
Vlooswijk C; Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands., Janssen SHM; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands., van de Poll-Franse LV; Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT, Utrecht, The Netherlands.; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.; Department of Medical and Clinical Psychology, Tilburg University, 5037 AB, Tilburg, The Netherlands., Bijlsma R; Department of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Centers, 1105 AZ, Amsterdam, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands., Lalisang RI; Department of Internal Medicine, Division of Medical Oncology, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, 6229 HX, Maastricht, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands., Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081 HV, Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands., Husson O; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. o.husson@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands. o.husson@nki.nl.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands. o.husson@nki.nl.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2023 Sep 13; Vol. 7 (1), pp. 93. Date of Electronic Publication: 2023 Sep 13.
Autor:
Janssen SHM; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Vlooswijk C; Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Manten-Horst E; Dutch AYA 'Young & Cancer' Care Network, Utrecht, The Netherlands., Sleeman SHE; Dutch AYA 'Young & Cancer' Care Network, Utrecht, The Netherlands., Bijlsma RM; Department of Medical Oncology, University Medical Center, Utrecht, The Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Lalisang RI; Department of Internal Medicine, GROW-School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, Maastricht, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Husson O; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13712-13731. Date of Electronic Publication: 2023 Apr 29.